Specific inhibition of bcr-abl gene expression by small interfering RNA in bcr-abl plus cells

被引：0
|
作者：
Scherr, M
Battmer, K
Winkler, T
Heidenreich, O
Ganser, A
Eder, M
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Univ Tubingen, Tubingen, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
476
引用
收藏
页码：S143 / S143
页数：1
相关论文
共 50 条
  • [41] IMPLEMENTING A CERTIFIED PLASMID REFERENCE MATERIAL FOR COPY NUMBER CALIBRATION DEMONSTRATES GOOD REPORTING CORRELATION BETWEEN % BCR-ABL/ABL (IS) AND % BCR-ABL/ABL (COPY NUMBER) IN XPERT® BCR-ABL ULTRA
    Huang, S.
    Sacha, T.
    Colomar, D.
    Borg, K.
    Lockwood, C.
    Payton, J.
    Uy, G.
    Schiffer, C.
    Feldman, G.
    Bossler, A.
    Woolworth, J.
    Mims, A.
    Levitas, A.
    Shridhar, K.
    Xiao, V.
    Wu, N.
    Wei, H.
    Lykke, C.
    Bates, M.
    Wong, W.
    Day, G. J.
    HAEMATOLOGICA, 2016, 101 : 452 - 452
  • [42] Inhibition of the Bcr-Abl oncoprotein by Bcr requires phosphoserine 354.
    Hawk, N
    Liu, JX
    Sun, T
    Wang, Y
    Wu, Y
    Arlinghaus, RB
    BLOOD, 2001, 98 (11) : 167B - 168B
  • [43] WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells
    Elmaagacli, AH
    Koldehoff, M
    Peceny, R
    Klein-Hitpass, L
    Ottinger, H
    Beelen, DW
    Opalka, B
    HAEMATOLOGICA, 2005, 90 (03) : 326 - 334
  • [44] The ne plus ultra for deep BCR-ABL sequencing?
    Mueller, Martin C.
    BLOOD, 2013, 122 (09) : 1536 - 1537
  • [45] Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins
    Skourides, PA
    Perera, SA
    Ren, RB
    ONCOGENE, 1999, 18 (05) : 1165 - 1176
  • [46] Polarized distribution of Bcr-Abl in migrating myeloid cells and co-localization of Bcr-Abl and its target proteins
    Paris A Skourides
    Samanthi A Perera
    Ruibao Ren
    Oncogene, 1999, 18 : 1165 - 1176
  • [47] Selective killing of BCR-ABL positive cells with a specific inhibitor of the ABL tyrosine kinase
    Druker, BJ
    Ohno, S
    Buchdunger, E
    Tamura, S
    Zimmermann, J
    Lydon, NB
    CANCER GENES: FUNCTIONAL ASPECTS, 1996, 7 : 255 - 267
  • [48] BCR-ABL RNA IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
    SHTIVELMAN, E
    GALE, RP
    DREAZEN, O
    BERREBI, A
    ZAIZOV, R
    KUBONISHI, I
    MIYOSHI, I
    CANAANI, E
    BLOOD, 1987, 69 (03) : 971 - 973
  • [49] Development of an integrated assay for detection of BCR-ABL RNA
    Winn-Deen, Emily S.
    Helton, Bret
    Van Atta, Reuel
    Wong, Wendy
    Peralta, Jeffrey
    Wang, James
    Tsongalis, Gregory J.
    Belloni, Dorothy
    Chan, David
    Eshleman, James R.
    Gocke, Christopher D.
    Jobbagy, Zsolt
    Beppu, Lan
    Radich, Jerald P.
    CLINICAL CHEMISTRY, 2007, 53 (09) : 1593 - 1600
  • [50] Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein
    Elzinga, Baukje M.
    Nyhan, Michelle J.
    Crowley, Lisa C.
    O'Donovan, Tracey R.
    Cahill, Mary R.
    McKenna, Sharon L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (06) : 455 - 462
12345